Zai Lab and argenx announce NMPA approval for sBLA for VYVGART Hytrulo [Yahoo! Finance]
Zai Lab Limited - American Depositary Shares (ZLAB)
US:NASDAQ Investor Relations:
zailaboratory.com/about/investors.php
Company Research
Source: Yahoo! Finance
license application (sBLA) for VYVGART Hytrulo 1,000mg vial for treating chronic inflammatory demyelinating polyneuropathy (CIDP) in adults. This once-weekly 30-90-second subcutaneous (SC) injection reportedly marks the first and only approval in China for a therapy to treat this immune-mediated neuromuscular disorder of the peripheral nervous system. The approval is based on the positive outcome of the randomised, double-blind, placebo-controlled multicentre ADHERE study. The trial comprised an open-label period to detect responders, followed by a randomised-withdrawal, double-blinded period to further evaluate the therapy. Patients from the Greater China region were enrolled in the ADHERE trial by Zai Lab, and the treatment response observed was in line with global study results. A 69% reduction in the risk of relapse with VYVGART Hytrulo compared to placebo was shown in a subgroup analysis of Chinese individuals. Furthermore, 78% of Chinese individuals showed clinical imp
Show less
Read more
Impact Snapshot
Event Time:
ZLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZLAB alerts
High impacting Zai Lab Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ZLAB
News
- Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)Business Wire
- Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary SharesBusiness Wire
- Analyst Estimates: Here's What Brokers Think Of Zai Lab Limited (NASDAQ:ZLAB) After Its Third-Quarter Report [Yahoo! Finance]Yahoo! Finance
- Zai Lab Announces Pricing of Public Offering of American Depositary Shares [Yahoo! Finance]Yahoo! Finance
- Zai Lab Announces Pricing of Public Offering of American Depositary SharesBusiness Wire
ZLAB
Earnings
- 11/12/24 - Beat
ZLAB
Sec Filings
- 11/15/24 - Form 8-K
- 11/15/24 - Form 424B5
- 11/14/24 - Form SC
- ZLAB's page on the SEC website